Sofgen Pharma S.A PROCF

0.00 0.00 NaN as of 24 Sep
Market cap
$114.0M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '24 Dec '23 Dec '22 Sep '22 Dec '21 Sep '21 Dec '20 Sep '20 Dec '19 Sep '19
Cash and Short Term Investments
30.32 23.82 43.00 43.00 72.11 72.11 4.23 0.96 — 0.03
Receivables
78.32 124.85 106.42 153.26 117.45 118.60 96.49 — — —
Inventory
76.54 101.83 99.76 96.83 79.43 79.43 64.28 — — —
Other current assets
9.74 6.82 8.93 4.34 6.99 27.92 2.92 0.10 — —
Total current assets
216.75 275.65 279.30 297.44 298.06 298.06 184.70 1.05 — 0.03
Property, Plant, Equpment (Net)
93.72 90.98 70.59 112.98 72.64 112.81 70.34 — — —
Long-Term Investments
1.54 2.03 1.51 1.72 2.44 2.70 2.46 201.32 — —
Goodwill and Intangible Assets (Total)
30.31 42.87 37.97 38.00 36.97 36.97 34.45 — — 0.00
Long Term Assets (Tax, Deferred)
28.26 10.48 7.49 — 7.07 — 21.77 — — —
Long-term assets (Other)
0.77 3.84 3.29 3.08 4.79 4.53 2.63 — — —
Total non-current assets
194.95 196.85 163.23 — 164.08 — 174.84 201.32 — 0.21
Total Assets
411.69 472.50 442.53 460.19 462.14 462.14 359.54 202.38 0.00 0.24
Notes Payable
38.75 — — — — — — — — 0.18
Accrued Expenses
10.10 8.31 — — — — — 0.14 — 0.06
Current Part of Debt
233.71 289.62 277.18 257.53 83.10 74.65 123.24 — — —
Current Part of Taxes to Pay
6.71 7.82 6.93 — 11.76 — 9.39 — — 0.00
Other current liabilities
19.67 34.76 11.62 23.24 7.73 31.40 12.88 0.14 — —
Total current liabilities
415.92 433.57 386.29 368.37 187.96 187.96 239.63 0.14 — 0.23
Long Term Debt (Total)
41.41 31.11 29.17 28.41 178.72 178.72 351.90 — — —
Long Term Tax Liability (Deferred)
0.69 2.49 6.75 0.85 6.07 (1.00) 18.89 — — —
Non-current Liabilities (Other)
5.76 6.07 57.46 57.46 127.72 127.72 3.80 197.23 — —
Total non-current liabilities
47.86 39.67 93.38 — 312.51 — 374.59 197.23 — —
Total liabilities
463.78 473.24 479.66 462.07 500.48 500.48 614.22 197.38 — 0.23
Additional Paid In Capital
57.09 50.24 45.74 — 42.75 — 39.90 17.56 — 0.02
Common Stock (Net)
393.86 376.50 378.69 1.01 378.69 1.01 56.41 0.00 — 0.00
Retained Earnings
(471.42) (396.29) (432.54) (391.51) (431.06) (431.06) (327.34) (12.56) — (0.02)
Shareholders Equity (Other)
0.19 — — — — — — — — 0.00
Common Equity (Total)
(52.09) (0.74) (37.13) (0.94) (38.34) (37.40) (254.68) 5.00 — 0.01
Shareholders Equity (Total)
(52.09) (0.74) (37.13) (0.94) (38.34) (37.40) (254.68) 5.00 — 0.01
Shareholders Equity and Liabilities (Total)
411.69 472.50 442.53 — 462.14 — 359.54 202.38 — 0.24
Shares (Common)
101.11 101.11 101.11 — 112.82 — — 7.83 — 5.03
Shareholders Equity (Tangible)
(82.40) (43.61) (75.10) — (75.31) — (289.12) 5.00 — 0.01
Net Debt
244.80 296.91 263.35 242.93 189.70 181.25 470.91 (0.96) — (0.03)
Total Debt
275.12 320.74 306.35 285.94 261.82 253.37 475.14 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates